Skip to main content
Premium Trial:

Request an Annual Quote

BioImagene Buys TissueInformatics from Icoria for Undisclosed Sum

NEW YORK, June 15 (GenomeWeb News) - BioImagene today said it has acquired TissueInformatics from Clinical Data's Icoria business unit for an undisclosed amount.

 

The Pittsburgh-based tissue image-analysis company develops and applies automated pathology software to enable researchers to quantitatively analyze tissue changes in drug discovery, disease assessment, toxicology, and tissue engineering research.

 

BioImagene, based in Cupertino, Calif., said the acquisition will boost its presence on the East Coast; expand its footprint in the tox-path area market; and help meet a demand for integrated tissue image-analysis and data- and image-management and -mining products.

 

BioImagene said it plans to "rapidly" integrate TissueInformatics' core technology into its platform and application suite.

 

TissueInformatics' management team will help plant BioImagene's presence on the East coast and will maintain its facilities in Pittsburgh, the company said.

 

Clinical Data acquired Icoria last year for around $12.5 million. In 2004 Icoria changed its name from Paradigm Genetics  after its acquisition of TissueInformatics earlier that year enabled it to change the focus of its business from plant genomics to systems biology and healthcare.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.